3 months ago
8
1
Posted On: July 18th 2026, 10:14 am
A new 10-year study is being hailed as one of the most significant advances in prostate cancer treatment for a generation.
Published this week in European Urology, the landmark study followed 3,477 men treated with focal therapy across 14 UK hospitals over a 10-year period. The results demonstrate outstanding long-term cancer control, with outcomes comparable to surgery and radiotherapy, while dramatically reducing the risk of urinary incontinence, erectile dysfunction and bowel problems for many suitable men.
For decades, men have been led to believe they had to choose between curing their cancer and protecting their quality of life.
This study changes that conversation.
It provides the strongest evidence yet that, for many men with localised prostate cancer, treating only the cancerous area of the prostate can deliver excellent long-term cancer control while preserving the things that matter most – continence, sexual function and quality of life.
For almost eight years, Prost8 has been the UK's only charity dedicated to helping men understand focal therapy and access specialist centres where it is appropriate. Today's landmark publication doesn't change our mission – it validates it.
We've always believed that prostate cancer treatment should be about saving lifestyles as well as lives. This new evidence brings us one step closer to ensuring every suitable man is routinely told about focal therapy before making one of the biggest decisions of his life.
Focal therapy isn't the right treatment for every man.
But every suitable man deserves to know it's an option.
If you or someone you know has recently been diagnosed with localised prostate cancer, don't make one of the biggest decisions of your life until you understand every appropriate treatment option available to you.
✅ Ask about all appropriate treatment options.
✅ Ask whether focal therapy could be right for you.
Learn more at www.prost8.org.uk
Eight years of campaigning. Ten years of evidence. One conversation that must now change.
Published this week in European Urology, the landmark study followed 3,477 men treated with focal therapy across 14 UK hospitals over a 10-year period. The results demonstrate outstanding long-term cancer control, with outcomes comparable to surgery and radiotherapy, while dramatically reducing the risk of urinary incontinence, erectile dysfunction and bowel problems for many suitable men.
For decades, men have been led to believe they had to choose between curing their cancer and protecting their quality of life.
This study changes that conversation.
It provides the strongest evidence yet that, for many men with localised prostate cancer, treating only the cancerous area of the prostate can deliver excellent long-term cancer control while preserving the things that matter most – continence, sexual function and quality of life.
For almost eight years, Prost8 has been the UK's only charity dedicated to helping men understand focal therapy and access specialist centres where it is appropriate. Today's landmark publication doesn't change our mission – it validates it.
We've always believed that prostate cancer treatment should be about saving lifestyles as well as lives. This new evidence brings us one step closer to ensuring every suitable man is routinely told about focal therapy before making one of the biggest decisions of his life.
Focal therapy isn't the right treatment for every man.
But every suitable man deserves to know it's an option.
If you or someone you know has recently been diagnosed with localised prostate cancer, don't make one of the biggest decisions of your life until you understand every appropriate treatment option available to you.
✅ Ask about all appropriate treatment options.
✅ Ask whether focal therapy could be right for you.
Learn more at www.prost8.org.uk
Eight years of campaigning. Ten years of evidence. One conversation that must now change.
Comments (1)
More posts
